The HDAC inhibitor valproate induces a bivalent status of...

Oncotarget 2017 / 06 Vol. 8; Iss. 23

The HDAC inhibitor valproate induces a bivalent status of the CD20 promoter in CLL patients suggesting distinct epigenetic regulation of CD20 expression in CLL in vivo

Scialdone, Annarita, Hasni, Muhammad Sharif, Damm, Jesper Kofoed, Lennartsson, Andreas, Gullberg, Urban, Drott, Kristina
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
8
Language:
english
Journal:
Oncotarget
DOI:
10.18632/oncotarget.16964
Date:
June, 2017
File:
PDF, 1.89 MB
english, 2017
Conversion to is in progress
Conversion to is failed